These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34585899)

  • 1. Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective.
    Mahashur A; Vora A; Waghray P; Jafrey SZ; Karadkhele A; Muchhala S; Rathod R; Suvarna V
    J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.
    Yong SJ
    Med Hypotheses; 2021 Aug; 153():110628. PubMed ID: 34139599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
    Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.
    Pehote G; Vij N
    Cells; 2020 Aug; 9(9):. PubMed ID: 32847034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Chiner-Vives E; Cordovilla-Pérez R; de la Rosa-Carrillo D; García-Clemente M; Izquierdo-Alonso JL; Otero-Candelera R; Pérez-de Llano L; Sellares-Torres J; de Granda-Orive JI
    Arch Bronconeumol; 2022 Apr; 58 Suppl 1():39-50. PubMed ID: 35501222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pidotimod: a review of its pharmacological features and clinical effectiveness in respiratory tract infections.
    Zhao N; Liu C; Zhu C; Dong X; Liu X
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):803-818. PubMed ID: 31603361
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
    Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
    Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
    Valentini D; Di Camillo C; Mirante N; Marcellini V; Carsetti R; Villani A
    Ital J Pediatr; 2020 Mar; 46(1):31. PubMed ID: 32164747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pidotimod: In-depth review of current evidence.
    Mahashur A; Thomas PK; Mehta P; Nivangune K; Muchhala S; Jain R
    Lung India; 2019; 36(5):422-433. PubMed ID: 31464215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspective.
    Bajire SK; Shastry RP
    Mol Cell Biochem; 2024 Mar; 479(3):591-601. PubMed ID: 37129767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
    Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
    Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
    Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):421-426. PubMed ID: 32153171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
    Oh TK; Song IA
    BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
    Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
    Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pidotimod activity against chronic bronchitis exacerbations.
    Ciaccia A
    Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
    Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.